Showing 1261-1270 of 2524 results for "".
- Industry Vet Matthew Hill Named CFO at Apyx Medical Corporationhttps://modernaesthetics.com/news/industry-vet-matthew-hill-named-cfo-at-apyx-medical-corporation/2473534/Matthew Hill is Apyx Medical Corporation’s (new Chief Financial Officer (CFO), effective December 4, 2023. Mr. Hill succeeds Tara Semb, whose departure was announced by the Company on November 9, 2023. “With its innovative Renuvion technology, large, global m
- Amogh Kothare Is Advalight’s New Chief Scientific Officerhttps://modernaesthetics.com/news/amogh-kothare-is-advalights-new-chief-scientific-officer/2473532/Amogh Kothare is the new Chief Scientific Officer of Advalight. In this role, Mr. Kothare will be responsible for clinical research, partnerships, product management, and clinical affairs and training to further leverage the brand. A "Under Amogh's sci
- Aesthetic Trend Spotting With New York City Facial Plastic Surgeon Dr. Jennifer Levinehttps://modernaesthetics.com/news/aesthetic-trend-spotting-with-new-york-city-facial-plastic-surgeon-dr-jennifer-levine/2473529/Regenerative aesthetics and other novel treatments are changing the way that doctors and patients think about and approach facial aging. New York City facial plastic surgeon Jennifer Levine, MD, spoke to AestheticsWire about regenerative aesthetics and other hot trends during
- New York City Plastic Surgeon Dr. Scot Bradley Glasberg Named New Plastic Surgery Foundation Presidenthttps://modernaesthetics.com/news/new-york-city-plastic-surgeon-dr-scot-bradley-glasberg-named-new-plastic-surgery-foundation-president/2473525/Scot Bradley Glasberg, MD, FACS, is the new president of The Plastic Surgery Foundation (The PSF), which supports research and international efforts of the American Society of Plastic Surgeons (ASPS). He began his one-year term at the Plastic Surgery: The Meeting in Austin, Texas.
- Study Highlights Benefits of Nonsurgical Rhinoplasty With PDO Max Threadshttps://modernaesthetics.com/news/study-highlights-benefits-of-nonsurgical-rhinoplasty-with-pdo-max-threads/2473521/Non-surgical rhinoplasty using polydioxanone (PDO) threads can safely achieve minor nasal changes especially in tip rotation and appearance of dorsal hump, according to research in the Journal of Cosmetic Dermatology. The pr
- Modern Aesthetics® Named Exclusive Media Partner for Octane’s Aesthetics Tech Forum for Second Year in a Rowhttps://modernaesthetics.com/news/modern-aesthetics-named-exclusive-media-partner-for-octanes-aesthetics-tech-forum-for-second-year-in-a-row/2473520/Modern Aesthetics® magazine is the exclusive media partner for Octane’s Aesthetics Tech Forum for the second consecutive year. This year’s Forum will take place at the Balboa Bay Resort in Newport Beach, Calif. January 25-26, 2024.
- Natrelle Unveils New "For Every BODY" Campaignhttps://modernaesthetics.com/news/natrelle-unveils-new-for-every-body-campaign/2473519/Allergan Aesthetics’ is launching "For Every BODY," a new Natrelle campaign that showcases how the Natrelle breast implant portfolio can provide a customized look for every body. "Our mar
- New Hydrafacial Booster Alert: Hydrafacial X Dr. Dennis Gross Skincare's Phyto-Retinol Boosterhttps://modernaesthetics.com/news/new-hydrafacial-booster-alert-hydrafacial-x-dr-dennis-gross-skincares-phyto-retinol-booster/2473518/The Beauty Health Company’s Hydrafacial is introducing Hydrafacial and Dr. Dennis Gross Phyto-Retinol Firming Booster. The new Hydrafacial and Dr. Dennis Gross Phyto-Retinol Firming Booster works on three different levels of the skin to help increase hydration, improve radiance, a
- Dr. Sherard A. Tatum Named New AAFPRS Presidenthttps://modernaesthetics.com/news/dr-sherard-a-tatum-named-new-aafprs-president/2473514/New York-based facial plastic and reconstructive surgeon Sherard A. Tatum, MD, is the new President of the
- Allergan Reports Positive Phase 3 Data for New Short-acting Neurotoxinhttps://modernaesthetics.com/news/allergans-trenibotulinumtoxine-bonte-smoothes-glabellar-lines-quickly/2473513/Allergan Aesthetics’ trenibotulinumtoxinE (BoNT/E) performed well for the treatment of moderate to severe glabellar lines, according to topline results from two pivotal Phase 3 studies. BoNT/E is a novel botulinum neurotoxin serotype E with a quick onset of action